Trübenbacher Luisa, Lindenberg Nicole, Graf Bernhard M, Backmund Markus, Unglaub Wilhelm, Lassen Christoph L
Centre for Interdisciplinary Pain Medicine, Department of Anaesthesiology, University Hospital of Regensburg, Regensburg, 93053, Germany.
"Praxiszentrum im Tal", Tal 9, 80331, Ludwig-Maximilians-University, Munich, Germany.
J Pain Res. 2024 Mar 14;17:1067-1076. doi: 10.2147/JPR.S421841. eCollection 2024.
Opioid induced hyperalgesia (OIH) describes a state of altered pain sensation due to opioid exposure. It often occurs among persons with opioid use disorder receiving substitution therapy.
The purpose of this study was to find out, whether OIH diagnosis could be facilitated by an objective pain indicating marker: the Nociceptive Flexion Reflex (NFR). Forty persons with opioid use disorder, 20 of them maintained on methadone and 20 treated with buprenorphine, as well as a control group of 20 opioid-free subjects, were examined. It was aimed to find out whether and in which way these opioid agonists alter reflex threshold (NFR-T). A cold-pressor test was performed to investigate the prevalence of OIH. Furthermore, electrical stimulation and electromyography analyzation were used for NFR-T measurement. Subjective pain ratings were evaluated with a numeric rating scale.
Significantly increased sensitivity to cold pressor pain was found in both maintenance groups when compared to their opioid-free counterparts (p < 0.001). Neither methadone nor buprenorphine showed any effect on NFR-T. This might be explained by the reflex approaching at the wrong location in the central nervous system. Consequently, NFR-T is not a suitable marker for diagnosing OIH.
Although methadone and buprenorphine have been proven to cause OIH, no effect on NFR-T was observed. A statistically significant effect could have been observed with a larger number of participants. Further research, with special focus on patients' adjuvant medication, should be conducted in the future, to facilitate diagnosis of OIH and provide appropriate pain management for maintenance patients.
阿片类药物诱导的痛觉过敏(OIH)描述了由于接触阿片类药物而导致的疼痛感觉改变的状态。它经常发生在接受替代疗法的阿片类药物使用障碍患者中。
本研究的目的是找出一种客观的疼痛指示标志物——伤害性屈曲反射(NFR)是否有助于OIH的诊断。研究人员对40名阿片类药物使用障碍患者进行了检查,其中20人维持美沙酮治疗,20人接受丁丙诺啡治疗,另外还有20名无阿片类药物的受试者作为对照组。旨在找出这些阿片类激动剂是否以及以何种方式改变反射阈值(NFR-T)。进行冷加压试验以调查OIH的患病率。此外,使用电刺激和肌电图分析来测量NFR-T。用数字评分量表评估主观疼痛评分。
与无阿片类药物的对照组相比,两个维持治疗组对冷加压疼痛的敏感性均显著增加(p < 0.001)。美沙酮和丁丙诺啡对NFR-T均无任何影响。这可能是由于反射在中枢神经系统中的定位错误所致。因此,NFR-T不是诊断OIH的合适标志物。
尽管已证明美沙酮和丁丙诺啡会导致OIH,但未观察到对NFR-T有影响。如果有更多参与者,可能会观察到统计学上的显著效果。未来应进行进一步研究,特别关注患者的辅助用药,以促进OIH的诊断并为维持治疗患者提供适当的疼痛管理。